Mach7 Technologies logo

Mach7 Technologies(ASX) M7T

Market CapA$51.70MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2016)-65%
5 Year-78%
1 Year-27%
1 Month-22%
A$0.22
-2.27%
-0.01Today
Mach7 Technologies last closing stock price
MetricPriceDate
Last closeAUD 0.222026-10-09
Mach7 Technologies stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-6.52%AUD 0.232026-10-02
1 month-21.82%AUD 0.282026-09-09
3 month-30.65%AUD 0.312026-07-10
Year to date-65.04%AUD 0.622025-12-31
1 year-27.12%AUD 0.302025-10-09
3 year-69.29%AUD 0.702023-10-10
5 year-77.84%AUD 0.972021-10-08
Since inception-65.08%AUD 0.632016-04-11

Mach7 Technologies Financials at a Glance

Market Cap

A$51.70MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

A$61.70M

Net Income (TTM)

-A$15.13M

EPS (TTM)

-A$0.04

P/E Ratio

-5.79

Dividend

A$0.00

Beta (Volatility)

-0.11 (Low)

Price

A$0.22

Volume

127,447

Open

A$0.22

Previous Close

A$0.22

Daily Range

A$0.22 - A$0.22

52-Week Range

A$0.22 - A$0.69

Estimated Earnings Date

Mar 3, 2027

M7T News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Mach7 Technologies

Mach7 Technologies Limited specializes in developing and commercializing medical imaging and data management software solutions for healthcare organizations globally. The company offers innovative tools that enhance the efficiency and accessibility of medical imaging, catering to a diverse range of healthcare providers.

Products and Services
  • eUnity enterprise diagnostic viewer for remote access to medical images
  • Vendor-neutral archive (VNA) for comprehensive data management
  • Workflow applications including teleradiology services and quality control tools
Growth Outlook
  • Recent quarterly revenue reached AUD 14.26 million, indicating strong market demand
  • Trailing twelve months (TTM) revenue shows a significant increase compared to previous periods
  • Expansion into international markets is expected to drive future growth
Financial Highlights
  • TTM revenue of AUD 54.5 million reflects a robust growth trajectory
  • Cash and cash equivalents stood at AUD 19.92 million as of June 2026
  • Current ratio of 1.84 indicates strong liquidity position
Mach7 Technologies Limited is positioned in the healthcare information services sector, focusing on enhancing medical imaging capabilities. The company's innovative products, such as the eUnity viewer and vendor-neutral archive, are designed to streamline workflows and improve patient care. Recent financial performance highlights a growing revenue base, with a notable increase in quarterly revenue, suggesting a positive market response to its offerings. The company's strong liquidity position, as indicated by its current ratio, further supports its operational stability. With ongoing expansion efforts and a commitment to innovation, Mach7 Technologies Limited presents a compelling opportunity for potential investors interested in the healthcare technology sector.
AI Generated • Sep 19, 2026

Industry

Health Care Technology

Sector

Health Care

CEO

Teri Thomas

Website

www.mach7t.com

Headquarters

Melbourne, VIC 3000, AU

M7T Financials

Key Financial Metrics (TTM)

Gross Margin

-6.76%

Operating Margin

-27.66%

Net Income Margin

-31.99%

Return on Equity

-24.29%

Return on Capital

-22.28%

Return on Assets

-17.68%

Earnings Yield

-17.27%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

A$51.70MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

235.01M

Volume

127.45K

Avg. Volume

81.92K

Financials (TTM)

Gross Profit

A$6.50M

Operating Income

-A$12.58M

EBITDA

-A$1.91M

Operating Cash Flow

-A$395.58K

Capital Expenditure

-A$824.66K

Free Cash Flow

-A$1.22M

Cash & ST Invst.

A$19.92M

Total Debt

A$80.39K

Mach7 Technologies Performance Analysis

Mach7 Technologies annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20232023-06-30AUD 30,049,76611.0%
20242024-06-30AUD 29,112,863-3.1%
20252025-06-30AUD 33,768,19516.0%
20262026-06-30AUD 27,909,143-17.4%
Mach7 Technologies sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-12-3112.3%
Q42025-06-30-9.5%
Q22025-12-31-14.9%
Q42026-06-304.4%
Mach7 Technologies annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20232023-06-30AUD -0.00-74.9%
20242024-06-30AUD -0.03652.3%
20252025-06-30AUD -0.03-22.1%
20262026-06-30AUD -0.0447.3%
Mach7 Technologies sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-12-3144.2%
Q42025-06-30-135.1%
Q22025-12-31-35.4%
Q42026-06-3044.9%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2026YOY CHG

Revenue

A$14.26M

-9.7%

Gross Profit

A$540.29K

-86.0%

Gross Margin

3.79%

N/A

Market Cap

A$51.70MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

A$309.59K

N/A

Employees

167

N/A

Net Income

-A$3.18M

+4.7%

EBITDA

A$1.09M

+204.8%

Quarterly Fundamentals

Name
Q4 2026YOY CHG

Total Cash

A$19.92M

-23.9%

Total Debt

A$80.39K

-93.7%

Accounts Receivable

A$5.78M

+62.6%

Inventory

A$0.00

N/A

Long Term Debt

A$14.82K

-98.6%

Short Term Debt

A$65.58K

-63.8%

Return on Assets

-17.68%

N/A

Return on Invested Capital

-21.37%

N/A

Free Cash Flow

A$2.33M

-34.5%

Operating Cash Flow

A$2.37M

-35.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
SHG.AXSingular Health Group Ltd
A$0.17-2.94%
ATX.AXAmplia Therapeutics Limited
A$0.11+0.00%
CMP.AXCompumedics Limited
A$0.25-5.77%
MX1.AXMicro-X Limited
A$0.06+18.52%

Trending Stocks

Symbol / CompanyPricePrice Chg
TAT&T
$22.14-9.97%
VEEAVeea
$6.19+59.95%
WFFWf
$4.03+96.54%
SPCXSpace Exploration Technologies
$162.08+0.94%

Questions About M7T

What is the current price of Mach7 Technologies?

Mach7 Technologies is trading at A$0.22 per share.

What is the 52-week range for Mach7 Technologies?

Over the past 52 weeks, Mach7 Technologies has traded between A$0.22 and A$0.69.

How much debt does Mach7 Technologies have?

As of the most recent reporting period, Mach7 Technologies reported total debt of A$80.39K.

How much cash does Mach7 Technologies have on hand?

Mach7 Technologies reported A$19.92M in cash and cash equivalents in its most recent financial results.

What is Mach7 Technologies’s dividend yield?

Mach7 Technologies does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services